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Abstract
Large deletions encompassing the NF1 gene and its ﬂanking regions belong to the group of genomic disorders caused by copy
number changes that are mediated by the local genomic architecture. Although nonallelic homologous recombination (NAHR)
is known to be amajormutational mechanism underlying such genomic copy number changes, the sequence determinants of
NAHR location and frequency are still poorly understood since few high-resolution mapping studies of NAHR hotspots have
been performed to date. Here, we have characterized twoNAHR hotspots, PRS1 and PRS2, separated by 20 kb and locatedwithin
the low-copy repeats NF1-REPa and NF1-REPc, which ﬂank the human NF1 gene region. High-resolution mapping of the
crossover sites identiﬁed in 78 type 1 NF1 deletions mediated by NAHR indicated that PRS2 is a much stronger NAHR hotspot
than PRS1 since 80% of these deletions exhibited crossovers within PRS2, whereas 20% had crossovers within PRS1. The
identiﬁcation of themost common strand exchange regions of these 78 deletions served to demarcate the cores of the PRS1 and
PRS2 hotspots encompassing 1026 and 1976 bp, respectively. Several sequence features were identiﬁed that may inﬂuence
hotspot intensity and direct the positional preference of NAHR to the hotspot cores. These features include regions of perfect
sequence identity encompassing 700 bp at the hotspot core, the presence of PRDM9 binding sites perfectly matching the
consensus motif for the most common PRDM9 variant, speciﬁc pre-existing patterns of histone modiﬁcation and open
chromatin conformations that are likely to facilitate PRDM9 binding.
Introduction
Neuroﬁbromatosis type 1 (NF1; MIM 162200) is a common disease
with an incidence at birth of ∼1/3000 (1,2). Large deletions of the
entireNF1 gene and itsﬂanking regions at 17q11.2 are observed in
∼5% of all patients with neuroﬁbromatosis type 1 (NF1) (3). Four
types of large NF1 deletion (type 1, type 2, type 3 and atypical)
have been identiﬁed, which differ with respect to the extent of
the deleted region and the locations of the respective breakpoints
(4). The majority of large NF1 deletions (70–80%) span 1.4–1.9 Mb,
as determined by multiplex ligation-dependent probe ampli-
ﬁcation (MLPA), a screening technique frequently used to detect
them (5). It has been generally assumed that most of these
1.4–1.9 Mb deletions have breakpoints located within low-copy
repeats, termed NF1-REPa and NF1-REPc. Large NF1 deletions
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spanning 1.4 Mb, with breakpoints located in NF1-REPa and NF1-
REPcmediated by nonallelic homologous recombination (NAHR),
have been designated ‘type 1 NF1 deletions’. Using MLPA as the
sole method of analysis, it is not immediately possible to distin-
guish between bona ﬁde type 1 NF1 deletions and atypical dele-
tions of similar size that are not associated with breakpoints
within the NF1-REPs and which are not mediated by NAHR. The
lack of resolution of MLPA is due to thewide spacing of the MLPA
probes ﬂanking the NF1-REPs (Fig. 1; Supplementary Material,
Fig. S1). The application of commercially available microarrays
to determine the precise extent of large NF1 deletions would
also be of limited utility owing to the lack of probes within the
highly homologous NF1-REPa and NF1-REPc repeats, a prerequis-
ite for accurate ascertainment of copy number changes.
Figure 1. (A) Schemaof the 17q11.2 region harbouring theNF1 gene and itsﬂanking genes. The size of the type 1NF1 deletion (1.4 Mb) is indicated by a grey bar. The vertical
red and green arrows represent the binding sites of theMLPA probes included in theMLPA kit P122, version C2. ForNF1 deletions encompassing 1.4–1.9 Mb, a proportion of
which are type 1, the target sequences for the probes shown in red are present in only one copy because they are locatedwithin the deletion region. By contrast, the target
sequences for theMLPAprobes shown in green arepresent in two copies since theyare not locatedwithin the deletion region. (B) Schematic representation of the structure
of NF1-REPa and NF1-REPc. The genomic positions indicated are according to hg19. (C) Positions of the genomic regions analysed to determine the degree of sequence
homology between NF1-REPa and NF1-REPc. The length of the respective regions is indicated in Supplementary Material, Table S27.
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In the study presented here, we systematically analysed a co-
hort of 68NF1 patients from the University Hospital Hamburg Ep-
pendorf, Germany (UKE cohort) who harboured 1.4–1.9 Mb NF1
deletions as initially determined by MLPA. The ﬁrst goal of our
analysis was to ascertain how many of these deletions were in-
deed bona ﬁde 1.4 Mb type 1 NF1 deletions mediated by NAHR
and possessing breakpoints located in homologous regions of
NF1-REPa and NF1-REPc. Since the resolution of the MLPA assay
would have been insufﬁcient to be able to assign the deletion
breakpoints unambiguously, we performed breakpoint-spanning
polymerase chain reactions (PCRs) to identify the breakpoints lo-
cated within the known NAHR hotspots PRS1 and PRS2 (Supple-
mentary Material, Fig. S2) (6,7). This provided a measure of the
relative proportions of the PRS1- versus PRS2-mediated dele-
tions, thereby yielding an indication of the relative activity of
these NAHR hotspots.
Although NAHR is an important mutational mechanism af-
fecting many regions of the human genome, little is known as
yet about the sequence features that inﬂuence NAHR position
and frequency (8). Meiotic NAHR and allelic homologous re-
combination (AHR) are thought to be mechanistically similar
processes (9,10) and both meiotic AHR- and NAHR-associated
crossovers occur in hotspots of a few kilobases (kb) in length
(6,11–17). PRDM9, a meiosis-speciﬁc methyltransferase, is an im-
portant regulator of meiotic AHR in many species including
human since it directs the genome-wide positioning of AHR hot-
spots via sequence-speciﬁc DNA binding of its zinc ﬁnger array
(18–23). PRDM9 is one of the most rapidly evolving genes in
the human genome, and many allelic variants have been de-
scribed (19,24–27). Different PRDM9 alleles have been shown to
activate different sets of AHR hotspots and to inﬂuence hotspot
strength differentially (18,19,28,29). A signiﬁcant enrichment of
the PRDM9 protein binding motif 5′ CCNCCNTNNCCNC 3′ has
been observed in the vicinity of NAHR sites, consistent with
both AHR and NAHR using identical recombination activating
binding motifs (30). Thus, PRDM9 is likely to play an important
role during NAHR as well as AHR.
In the study presented here, we investigated various se-
quence features of the NAHR hotspots PRS1 and PRS2, including
the number of potential PRDM9 binding sites, whichmay serve to
inﬂuence NAHR frequency. To maximize the number of PRS1-
and PRS2-mediated deletions under study, we additionally
screened a cohort of patients with suggested type 1NF1 deletions
initially ascertained in the Department of Genetics, University of
Alabama at Birmingham, USA (UAB cohort). By combining pa-
tients from the UKE and UAB cohorts, we were able to analyse
50 PRS2- and 28 PRS1-mediated NF1 deletions. We sequenced
across the sites of theNAHR-associated crossovers, the strand ex-
change regions (SERs) between NF1-REPa and NF1-REPc. The
high-resolution mapping of the hotspots then enabled us to de-
termine the extent of the PRS1 and PRS2 regions as well as the
most commonly used SERs that demarcate the highly active
cores of the NAHR hotspots. Our ﬁndings indicate that multiple
factors are likely to inﬂuence the increased rate of NAHR ob-
served within the hotspots PRS1 and PRS2.
Results
Proportion of PRS1- and PRS2-mediated NF1 deletions
We systematically investigated 68 unrelated NF1 patients (UKE
cohort) with putative type 1 deletions according toMLPA to deter-
mine whether their deletions were indeed bona ﬁde type 1
deletions mediated by NAHR (Supplementary Material, Tables
S1–S4). Further, we determined the relative proportions of
PRS1- versus PRS2-mediated deletions, which have not been pre-
viously ascertained. Breakpoint-spanning PCR and sequence
analysis of the breakpoint-spanning PCR products (BSPs) indi-
cated that 52 deletions (76.5%) were PRS2-mediated, whereas 13
deletions (19.1%) exhibited breakpoints within PRS1. Three dele-
tions (4.4%) did not exhibit breakpoints within either PRS1 or
PRS2. Our ﬁndings clearly indicate that the vast majority
(95.6%) of large NF1 deletions classiﬁed as type 1 according to
MLPA are indeed bona ﬁde type 1 deletions exhibiting break-
points located within the NAHR hotspots PRS1 and PRS2. The
ratio of PRS2-mediated to PRS1-mediated deletions is of the
order of 4:1.
Sequence analysis of the PRS2 hotspot
In our previous analysis (7), we determined the locations of the
SERs between NF1-REPa and NF1-REPc in 20 of the type 1 NF1 de-
letions from theUKE cohort, which exhibited breakpoints located
within the PRS2 hotspot. In order to identify the most common
SERs within PRS2, and hence the hotspot core, it was necessary
to analyse a much larger number of PRS2-positive deletions.
Therefore we sequenced the BSPs of four additional PRS2-
mediated deletions from the UKE cohort (Supplementary Mater-
ial, Table S5) as well as 26 PRS2-mediated deletions from the UAB
cohort (Supplementary Material, Table S6). These 26 deletions
were initially identiﬁed by MLPA. Sequence analysis of BSPs per-
formed during the course of this study indicated that they all har-
boured breakpoints within PRS2. In total, we analysed the SERs in
50 PRS2-mediated type 1 NF1 deletions (Supplementary Material,
Table S7).
The SERs harbour the sites of NAHR-associated crossovers
and are ﬂanked by either paralogous sequence variants (PSVs)
or single nucleotide polymorphisms (SNPs) with a minor allele
frequency (MAF) of ≤1% that serve to distinguish NF1-REPa
from NF1-REPc. Within an SER, NF1-REPa and NF1-REPc exhibit
absolute sequence identity. Consequently, higher resolution of
the crossover locations within the SERs is not possible. The 50
PRS2-mediated deletions analysed exhibited crossovers within
13 different SERs ranging in size from 25 to 737 bp. According to
the genomic locations of these SERs, PRS2 extends over 4096 bp
(Supplementary Material, Fig. S2). Nine of the 13 SERs harboured
the crossovers of only one or two deletions. By contrast, SERs 4–7
were recurrent since a total of 40 deletions (80%) had crossovers
within these SERs (Supplementary Material, Table S8). SERs 4–7
span 1976 bp and represent the hotspot core (Fig. 2). We conclude
that the deletion breakpoints in PRS2 are non-randomly distribu-
ted, clustering within speciﬁc SERs (Fig. 2). The most commonly
encountered SERs (4 and 6) were detected in a total of 26 patients
(52%) (Supplementary Material, Table S8).
Sequence analysis of the PRS1 hotspot
Type 1 NF1 deletion breakpoints located within PRS1 have not
been extensively characterized as yet. We sequenced the BSPs
of the 13 PRS1-mediated type 1 deletions identiﬁed among the
68 patients from the UKE cohort (Supplementary Material,
Table S9). To maximize the number of PRS1-mediated deletions
under study, we also included 15 PRS1-mediated type 1 deletions
from the UAB cohort (Supplementary Material, Table S10). Taken
together, we were able to analyse 28 PRS1-mediated type 1
NF1 deletions and detected 11 different SERs within 5202 bp
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(Supplementary Material, Tables S11 and S12). The recurrent
SERs 4–7 harboured the crossovers of 20 deletions (71%) and re-
present the 1026 bp core of PRS1. Thus, clustering of crossovers
within a hotspot core is apparent in PRS1 as well as in PRS2, indi-
cating preferred sites of double-strand breaks (DSBs) and/or dou-
ble Holliday junction (dHj) resolution within both hotspots.
Figure 2. Localization of the SERs within PRS2 (A) and PRS1 (B). Predicted PRDM9 A-variant binding sites (A-motifs) are indicated by rectangles, whereas the predicted
binding sites of the less common PRDM9 C-variant (C-motifs) are indicated by triangles. PRDM9 binding sites shown in blue are located within NF1-REPa and NF1-
REPc, whereas those marked in green are speciﬁc to NF1-REPc. PRDM9 binding sites marked in blue and green are invariant since no SNPs are present within these
sequences that match perfectly with the binding site consensus sequence motif 5′ CCNCCNTNNCCNC 3′ for the PRDM9 A-variant (31) or with the binding site
consensus motif 5′ CCNCNNTNNNCNTNNC 3′ for the PRDM9 C-variant (32,33). The A-motif indicated in red is polymorphic; a perfect match to the 13 bp A-motif
consensus is only evident if the C-allele of SNP rs114479203 is present. The frequency of the C-allele of SNP rs114479203 was found to be 0.199 in Europeans (34).
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Gene conversion within PRS1 and PRS2
Sequence analysis of the BSPs also indicated sites of putative
gene conversion within PRS1 and PRS2 (Supplementary Material,
Tables S13–S17). To determine whether these gene conversion
events were associated with the deletion-causing NAHR or
whether they instead resulted fromnonallelic homologous recom-
binationwithout crossover (NAHGC) occurring in a previous gener-
ation, we analysed the non-recombinant (wild-type) PRS1 and
PRS2 sequences in the parents of the patients. NAHR-associated
gene conversion was observed in 4 of the 28 PRS1-mediated type
1 NF1 deletions (14%) and 5 of the 50 PRS2-mediated deletions
(10%) (SupplementaryMaterial, Table S17). The rateof gene conver-
sion events within PRS2 observed in our present study was higher
than noted previously (7). This discrepancy may be explained in
terms of the analysis of a larger number of patients and improved
variation dataprovidedby the 1000GenomesProject,whichhelped
us to distinguish between SNPs with a higher allele frequency and
PSVs. In most instances, the gene conversion events affected only
single PSVs and did not impair the ascertainment of the SERs.
The majority of the gene conversion events detected here fa-
vouredGCalleles, whichwas suggestive of GC-biased gene conver-
sion. Within PRS2, we observed a GC content of 58.7%, which was
markedly higher than its ﬂanking regions and the local genomic
average (49.6% GC within 40.4 kb). By contrast, the GC content
within PRS1 was 52.8%, which was only moderately elevated
whencomparedwith the local averageGCcontent (Supplementary
Material, Fig. S3).
Sequence features of PRS1 and PRS2
PRDM9 binding sites
As part of our attempt to explore the sequence features of the
NAHR hotspots PRS1 and PRS2 that could account for the higher
incidence of NAHR events within PRS2 when compared with
PRS1, we screened both hotspots for the presence of putative
PRDM9 binding sites. The PRDM9 gene is highly polymorphic in
humans, with the PRDM9 A-allele being the most common
PRDM9 allele in Europeans (18,24,35–38) (Supplementary Mater-
ial, Table S18). The A-allelewas also themost common PRDM9 al-
lele in the healthy parents of 24 of the patients with type 1 NF1
deletions (SupplementaryMaterial, Tables S19 and S20). The par-
ents did not harbour the deletion in their somatic cells; rather,
the deletion occurred de novo in their germlines by meiotic
NAHR and was subsequently transmitted to their offspring.
Hence, it is very likely that the protein encoded by the PRDM9
A-allele initiated NAHR in PRS1 and PRS2. Three non-variant
andonepolymorphic PRDM9protein binding sites, perfectlymatch-
ing thePRDM9A-variant consensusmotif (5′CCNCCNTNNCCNC3′),
are located within in the core of PRS2 (Fig. 2; Supplementary Mater-
ial, Fig. S4 andTable S21). By contrast, PRDM9 binding sites perfectly
matching the consensus A-motif are absent from the core of PRS1
encompassing SERs 4–7 (Supplementary Material, Table S22). Only
binding sites exhibiting seven of eight matches to the consensus
motif were identiﬁed in the PRS1 core (Supplementary Material,
Table S23). Several PRDM9 C-variant binding sites are predicted to
be located within PRS1 and PRS2 (Fig. 2), but PRDM9 C-alleles are
much less frequent than A-alleles in Europeans and the transmit-
ting parents (Supplementary Material, Tables S18 and S19).
Distance between the SERs and the PRDM9 binding sites
We next calculated the distance between each NAHR-associated
SER locatedwithin PRS2 and the nearest predicted PRDM9A-vari-
ant binding site. The observed distances ranged from 111 to
1367 bp (Supplementary Material, Table S24). This analysis was
necessarily conﬁned to PRDM9 A-variant binding sites since the
parents of patients with PRS2-mediated deletions were invari-
ably carriers of the PRDM9 A-allele (Supplementary Material,
Table S19), which encodes the PRDM9 protein A-variant. This
variant speciﬁcally activates recombination events by binding
to the consensus sequence A-motif (19,24).
Although we were able to investigate only ﬁve transmitting
parents of patients with PRS1-mediated deletions, the PRDM9
A-allele was the most common allele in the deletion-transmit-
ting parents of these patients as well as in the general population
(Supplementary Material, Table S19). However, in contrast to
PRS2, only one PRDM9 A-variant binding site perfectly matching
the A-variant consensus motif is located in PRS1, some 2.3–3 kb
distant from the hotspot core (Fig. 2; Supplementary Material,
Fig. S4 and Table S25).
Chromatin and histone modiﬁcations
To investigate whether chromatin conformation and histone
modiﬁcations could serve to distinguish PRS1 and PRS2 from
their ﬂanking regions, we analysed ENCODE data for the regions
in question (39). Type 1NF1 deletions with breakpoints in PRS1 or
PRS2 aremostly ofmeiotic origin occurring in thematernal germ-
line (40). Hence, ideally, the chromatin state and histone modiﬁ-
cations within PRS1 and PRS2 should be analysed in oocytes.
However, germ cell lines were not included in the ENCODE pro-
ject. Since multipotent adult germline stem cells exhibit embry-
onic stem cell-like features (41), we opted to analyse the ENCODE
data obtained from the embryonic stem cell line H1-hESC as a
proxy for oocytes. In the centromeric portion of PRS1 and in the
core of PRS2, open chromatin states suggestive of promoter-like
features were identiﬁed, which were lacking from their ﬂanking
regions (Fig. 3; SupplementaryMaterial, Figs S5 and S6). These ob-
servations may at ﬁrst seem surprising since PRS1 and PRS2 are
not located upstreamof any functional gene in 17q11.2. However,
the evolutionary origin of PRS1 and PRS2 within the NF1-REPs
may be informative in this context. During primate genome evo-
lution, after the separation of the orang-utan from the human
lineage ∼14 Mya, a 32 kb sequence segment harbouring the an-
cestral PRS1 and PRS2 regions, located upstream of the LPHN1
gene at 19p13.2, was duplicated and transposed to 17q11.2 form-
ing part of one of the NF1-REPs (42). PRS1 and PRS2 are located
within this 32 kb duplicon paralogous to 19p13.12 (Fig. 1). The
19p13.12 PRS2 paralog may constitute an alternative promoter
for the LPHN1 gene (Supplementary Material, Fig. S7) and hence
may have retained its promoter-like open chromatin con-
formation after the duplicative transposition from 19p13.12 to
17q11.2. By contrast, the PRS1 region at 19p13.12 does not exhibit
promoter-like features (Supplementary Material, Fig. S7), al-
though it has acquired an open chromatin state characteristic
of a weak promoter after its duplicative transposition to 17q11.2
(Fig. 3; Supplementary Material, Fig. S5).
PRS1 and PRS2 clearly differ from their ﬂanking regions with
regard to their open chromatin/ promoter-like features. Further,
they also exhibit a very speciﬁc histone modiﬁcation pattern
which is lacking in their ﬂanking regions. In both PRS1 and
PRS2, histone H3 lysine 4 dimethylation (H3K4me2) was overre-
presented. In PRS2, H3K4me3, histone H2 acetylated at lysine 9
(H3K9ac) and histone H3 acetylated at lysine 27 (H3K27ac) were
enriched when compared with the ﬂanking regions (Fig. 3; Sup-
plementary Material, Fig. S6 and Table S26).
Both the open chromatin state within PRS1 and PRS2 and the
speciﬁc histone modiﬁcations in the vicinity were identiﬁed in
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theH1-hESCcell line, aswell as inothercell lines forwhichENCODE
data are available (Supplementary Material, Figs S8–S10).
Recombination rates within PRS1 and PRS2
During primate genome evolution, sequences at 19p13.12 were
duplicated and transposed to 17q11.2 giving rise to the NF1-
REPs including the PRS1 and PRS2 regions (42). A previous study
suggested that the progenitor sequences of PRS1 and PRS2 at
19p13.12 harbour hotspots of AHR (6). We evaluated the HapMap
Phase II data and observed a 2- to 3-fold increased recombination
rate in PRS1 and PRS2 of NF1-REPc as well as in their paralogous
regions at 19p13.12 when compared with the local average
recombination rate estimated from the recombination rates
observed within 100 kb ﬂanking PRS1 and PRS2 on both sides
(Supplementary Material, Fig. S11). Although the number of in-
formative SNPs within the NF1-REPs is low, our data concur
with the observations of De Raedt et al. (6) in that they support
the view that the NAHR hotspots PRS1 and PRS2 overlap with re-
gions of pre-existing AHR hotspots.
Sequence homology between the NF1-REPs
To investigate whether there are DNA sequence differences be-
tween NF1-REPa and NF1-REPc that might inﬂuence the location
of NAHR-associated strand exchanges, we performed BLAST se-
quence alignments. In this context, regions exhibiting 100% se-
quence homology (perfect identity) between the NF1-REPs are
particularly interesting since they may inﬂuence the recombin-
ation efﬁciency (43).Within PRS1 and PRS2, the average sequence
homology between NF1-REPa and NF1-REPc was 98% (Supple-
mentary Material, Tables S27 and S28). We did not observe any
differences between PRS1 and PRS2 in terms of the number of
regions spanning 200–300 bp that exhibited perfect sequence
identity between the NF1-REPs, although we did identify a
700 bp region within PRS2 (but not in PRS1) that exhibited perfect
sequence identity betweenNF1-REPa andNF1-REPc (Supplemen-
tary Material, Fig. S12).
Sequence alignments of 10 kb regions located centromeric
to PRS1 and PRS2, respectively, did not indicate striking differ-
ences with regard to the number of segments showing perfect
sequence identity betweenNF1-REPa andNF1-REPc (Supplemen-
tary Material, Figs S13A and S14A). However, sequence align-
ments of regions located telomeric to PRS1 and PRS2 revealed a
considerable number of differences. A high degree of sequence
homology between NF1-REPa and NF1-REPc was observedwithin
10 kb ﬂanking PRS1 in a telomeric direction (Supplementary
Material, Fig. S13B), but the sequence homology between NF1-
REPa and NF1-REPc ends abruptly 2.5 kb telomeric to PRS2
(Supplementary Material, Fig. S14B). This interruption in se-
quence homology could contribute to the positional preference
of dHj resolution within PRS2.
Discussion
The systematic analysis of 68 NF1 deletions from the UKE co-
hort, which were initially identiﬁed by MLPA and suggested to
be type 1, indicated that 65 (96%) were indeed bona ﬁde type 1
NF1 deletions. By deﬁnition, type 1 NF1 deletions encompass
1.4 Mb and are mediated by NAHR with crossovers occurring
within the two NAHR hotspots, PRS1 and PRS2. Thus, despite
thewide spacing of the MLPA probes employed (Supplementary
Material, Fig. S1), MLPA proved to be an effective technique
for the prediction of type 1 NF1 deletions. However, formal
Figure 3. Chromatin conformation and histonemodiﬁcations within PRS1 and PRS2 as well as their ﬂanking regions in the embryonic stem cell line H1-hESC according to
the ENCODE data (https://genome.ucsc.edu/) (39). The PRS1 and PRS2 regions within NF1-REPa (A) and NF1-REPc (B) are highlighted by dashed lines. Track 1 indicates the
chromatin state segmentation (Chrom-HMM) based on ChIP-seq data using a hidden Markov model (HMM). The coloured bars in Track 1 highlight predicted functional
elements and chromatin states: dark red, active promoter; light red, weak promoter; green, weakly transcribed; orange, strong enhancer; yellow, weak enhancer; blue,
insulator). Tracks 2–15 indicate histone modiﬁcations analysed by ChIP-seq. For every histone modiﬁcation type, signal (s) and peak (p) tracks are indicated. The peak
tracks show regions of statistically signiﬁcant histone modiﬁcation enrichment, whereas the signal tracks display density graphs of histone modiﬁcations. Track 16
indicates regions of open chromatin and/or transcription factor binding sites determined by combined data obtained by DNaseI hypersensitivity (HS) assay,
Formaldehyde-assisted isolation of regulatory elements (FAIRE) and chromatin immunoprecipitation (ChIP) for regulatory factors. Regions exhibiting features of open
chromatin conformation in Track 16 are indicated by rectangles according to the following colour code: blue, high signiﬁcance; green, low signiﬁcance, regions
identiﬁed by DNaseI HS assays but not by FAIRE as peaks; red, low signiﬁcance, regions identiﬁed by FAIRE as peaks but not identiﬁed by DNaseI HS; black, low
signiﬁcance, regions identiﬁed as peaks by both DNaseI HS and FAIRE; and pink, regions identiﬁed by ChIP-seq as peaks. In Tracks 17 and 18, CpG methylation
patterns are indicated. Short unmethylated regions observed only in PRS2 are indicated as blue bars.
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conﬁrmation of a bona ﬁde type 1 NF1 deletion is only possible
by means of breakpoint-spanning PCRs with primers that dis-
tinguish between the highly homologous NF1-REPa and NF1-
REPc. Therefore, we performed breakpoint-spanning PCRs in
order to conﬁrm that the NF1 deletions were indeed mediated
by NAHR and exhibited breakpoints located within PRS1 or
PRS2. Mapping of type 1 NF1 deletion breakpoints using com-
mercially available array CGH platforms is much less efﬁcient
than the breakpoint-spanning PCR approach due to the lack of
robust copy-number-sensitive array probes located close to
the NAHR hotspots. The analysis of the BSPs performed as
part of this study indicated that PRS2 is a 4-fold stronger
NAHR hotspot than PRS1. Of the 65 bona ﬁde type 1 NF1 dele-
tions of the UKE cohort, 52 (80%) exhibited crossovers within
PRS2, whereas only 13 (20%) were within PRS1. This difference
in hotspot strength between PRS1 and PRS2 has been observed
in previous studies (6,44–47) but has not been systematically
analysed before in terms of the precise proportions of PRS1- ver-
sus PRS2-mediated deletions.
To identify the sequence features characteristic of both hot-
spots, as well as those that might be responsible for the higher
frequency of NAHR-associated crossovers within PRS2 when
compared with PRS1, we included in our analysis 15 type 1 NF1
deletions identiﬁed in the UAB cohort of NF1 patients. In total,
we assessed 28 type 1 NF1 deletions with breakpoints in PRS1
and 50 PRS2-mediated deletions. We sequenced the respective
BSPs and determined the SERs between NF1-REPa and NF1-
REPc within both NAHR hotspots. The SER of an NAHR-mediated
deletion indicates the location of the dHj resolution and hence
the region of crossover (Fig. 4). Within PRS2, 13 SERs were identi-
ﬁed, encompassing 4096 bp, thereby indicating the extent of the
PRS2 hotspot. A clustering of crossovers within speciﬁc SERs was
observed since 40 (80%) of the 50 PRS2-mediated deletions exhib-
ited crossovers located within SERs 4–7. These SERs encompass
1976 bp and represent the hotspot core (Supplementary Material,
Table S8; Fig. 2).Within PRS1, 11 SERswere identiﬁed encompass-
ing 5202 bp. Consequently, the PRS1 hotspot is ∼1 kb longer than
that of PRS2. This notwithstanding, a clustering of crossoverswas
Figure 4.NAHRbetweenNF1-REPa andNF1-REPc according to theDNADSB repairmodel involving a dHj. ADSB is introduced at theNAHRhotspot either inNF1-REPa (A) or
in NF1-REPc (B). Subsequently, 5′ to 3′ resection occurs on one strand leaving 3′ single-stranded overhangs that invade the unbroken paralog, base pairing in the process
with the complementary strand and displacing the other strand to form a D-loop. The overhangs at the 3′ end remain unprocessed and demarcate the site of the original
DSB close to the PRDM9 binding site. New DNA synthesis is denoted by dotted lines with the unbroken paralogous strand serving as the template. The dHj is completed
after the ligation of the DNA ends and can be resolved either by crossover (as shown here) or by noncrossover (not shown). Two types of crossover resolution are possible,
distinguished by the sites of cleavage, either A + b or a + B. Both types of resolution yield a deletion (as shownhere) and a duplication chromatid (not shown). Heteroduplex
regions are corrected using the unbroken DNA strand as template. The SER representing the NAHR-associated crossover is marked by a black triangle. The 3′ end of the
recombination-initiating DSB (3′DSB) is located close to the PRDM9 binding site. The green rectangles indicate regions of PRDM9-modiﬁed nucleosomes. These
nucleosomes contain histone H3 trimethylated at lysine K4 (H3K4me3) by PRDM9 and serve to limit the branch migration of the dHj (48). The green rectangle
indicates the extent of the genomic region involved in forming the dHj.
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also detected in PRS1. Twenty (80%) of the 28 PRS1-mediated de-
letions exhibited crossovers in SERs 4–7 located within 1026 bp
(Supplementary Material, Table S12; Fig. 2). We therefore con-
clude that a strong positional preference must exist for NAHR
to be initiated within both hotspots which are separated from
each other by 20 kb (Fig. 1). Although NAHR-associated gene con-
version was observed in 4 of the 28 PRS1-mediated type 1NF1 de-
letions (14%) and 5 of the 50 PRS2-mediated deletions (10%)
(Supplementary Material, Table S17), it is unlikely that gene con-
version will have hampered the determination of the SERs. Most
of the gene conversion events detected here favoured GC alleles,
an observation consistent with previous reports of GC-biased
gene conversion being associated with recombination events in
a variety of different species (29,49–54). Within PRS2, and to a
lesser extent also in PRS1, we observed a higher GC content
when compared with their ﬂanking regions, most likely resulting
from GC-biased gene conversion within these hotspots. This
ﬁnding concurs with those of other NAHR hotspots in the
human genome (30).
It has been suggested that the synapsis of genomic regions ex-
hibiting extensive sequence homology is a prerequisite for the
pairing and crossover underlying NAHR (10,55). Hence, both the
frequency and location of NAHR within the NF1-REPs are likely
to be inﬂuenced by the degree of sequence homology (56). In
view of the fact that NF1-REPa and NF1-REPc exhibit on average
98% sequence homologywithin 46.4 kb (SupplementaryMaterial,
Table S28), the strong positional preference for NAHR to be in-
itiated within PRS1 and PRS2 is remarkable, with both hotspots
exhibiting narrow cores encompassing only 1026 and 1976 bp, re-
spectively. The NF1-REPs comprise several duplicate sequences
with different lengths, orientations and evolutionary origins
(SupplementaryMaterial, Fig. S1). Analysis of the sequence hom-
ology between the NF1-REPs indicated a continuous segment of
700 bp exhibiting perfect sequence identity between them; this
700 bp segment was present exclusively in PRS2, and neither in
PRS1 nor in the ﬂanking regions of either hotspot (Supplemen-
tary Material, Figs S12–S14). This 700 bp region of sequence iden-
tity overlaps with SER 7, located within the core of PRS2, andmay
well facilitate NAHR-associated strand invasion and dHj forma-
tion leading to the high number of crossovers within PRS2.
The sequence homology between NF1-REPa and NF1-REPc
ends abruptly 2.5 kb telomeric to PRS2 (Supplementary Material,
Fig. S14). This sharp drop in sequence homology may also con-
tribute to frequent crossovers within PRS2. By contrast, the
10 kb regions ﬂanking PRS1 on both sides exhibit continuous
high sequence homology (Supplementary Material, Figs S13
and S14). Our ﬁndings with PRS2 are reminiscent of the NAHR
hotspots within the Smith–Magenis syndrome-REPs at 17p11.2,
which were found to be located close to a discontinuity of se-
quence homology, suggesting that such boundaries might inﬂu-
ence the positioning of dHj resolution (55).
Although sequence homology promotes the occurrence of
NAHRevents, other DNA sequence features are also likely to con-
tribute to the observed positional preference of NAHR-associated
crossovers. The previous results (6) taken together with our own
analysis of recombination rates using the HapMap Phase II data
(Supplementary Material, Fig. S11) imply that the NAHR hotspots
PRS1 and PRS2 emerged on a background of pre-existing hotspots
for AHR originally present at paralogous positions in the progeni-
tor sequences of the NF1-REPs located at 19p13.12. AHR hotspots
have been shown to exhibit certain speciﬁc histonemodiﬁcations
in a variety of different species (Supplementary Material,
Table S26) (57–63). Remarkably, AHR hotspots occupy ‘bivalent
chromatin regions’ that harbour both active (H3K4me3) and
repressive (H3K27me3) marks. We observed a speciﬁc pattern
of histone modiﬁcation at the PRS1 and PRS2 hotspots that
was absent from their ﬂanking regions. In PRS2, and to a lesser
extent also in PRS1, H3K4me2 and H3K4me3 were signiﬁcantly
enriched (Fig. 3, Supplementary Material, Table S26). In PRS2,
but not in PRS1, H3K9ac and H3K27acwere also signiﬁcantly en-
riched. The speciﬁc histone modiﬁcation patterns and the open
chromatin organization within PRS1 and PRS2 may facilitate
NAHR. This pattern of histone modiﬁcation and open chroma-
tin was more pronounced in PRS2 than in PRS1, which may
also contribute to PRS2 being a stronger NAHR hotspot when
compared with PRS1 (Fig. 3; Supplementary Material, Figs S5
and S6).
In the present study, we assessed various other NAHR hot-
spots identiﬁed in previous studies (12,15,17,64,65) in order to as-
certain their histone modiﬁcation patterns and chromatin
conformations using the ENCODE data. However, the speciﬁc his-
tonemodiﬁcation patterns and open chromatin conformationwe
observed in association with the NAHR hotspots PRS1 and PRS2
have not been consistently observed features at these NAHR hot-
spots (data not shown). By contrast, a recent genome-wide study
of human deletion breakpoints suggested that NAHR-associated
breakpoints tend to occur in open chromatin and exhibit a high
density of speciﬁc histone modiﬁcations such as H3K4me2 and
H3K79me2 (66). This suggests ﬁrstly that a hierarchy of different
features may be involved in determining the location and inten-
sity of NAHRhotspots, and secondly that the pre-existing histone
modiﬁcation pattern or open chromatin state is not necessarily
relevant in all cases.
In addition to its open chromatin conformation and a speciﬁc
histone modiﬁcation pattern, PRS2 is also distinguishable from
PRS1 by the number and location of predicted PRDM9 binding
sites (Fig. 2; Supplementary Material, Fig. S4). As in the general
European population, the PRDM9 A-allele was found to be the
most common PRDM9 allele in the healthy parents of 24 patients
with type 1 NF1 deletions (Supplementary Material, Table S19).
Three non-polymorphic binding sites perfectly matching the
13-mer consensus binding motif for PRDM9 A-variants were pre-
dicted to be located within the core of PRS2 encompassing SERs
4–7. By contrast, PRDM9 A-variant binding sites perfectly match-
ing the consensus binding motif were absent from the core of
PRS1, and only PRDM9 A-variant binding sites with weaker
matches to the consensus motif were detected (Supplementary
Material, Table S23). Sperm-typing studies have shown that sin-
gle-point mutations in the 13 bp consensus motif for the PRDM9
A-variant can completely abolish hotspot activity (67–69). Conse-
quently, the absence of PRDM9 A-variant binding sites perfectly
matching the consensus binding motif close to the core of PRS1
may well contribute to a lower NAHR-initiation rate within
PRS1 when compared with PRS2. However, PRDM9 activity at
recombination hotspots is likely to be regulated in a complex
manner by cis-acting sequencemotifs aswell as by the local chro-
matin environment and trans-acting factors (70,71). This may
also be concluded from the identiﬁcation of humanAHRhotspots
that are dependent upon PRDM9 activity yet do not contain the
predicted PRDM9 binding motif (19,24). This notwithstanding,
in vitro studies have clearly indicated that the PRDM9 A-variant
protein exhibits high binding afﬁnity to the A-variant consensus
binding motif (13-mer) but only low afﬁnity to the 13-mer con-
sensusmotif if single nucleotides at conserved positions aremu-
tated (18). Furthermore, SNPs within the consensus PRDM9
binding sites have been shown to inﬂuence AHR hotspot activity
in humans (24). These ﬁndings lend support to our hypothesis
that the sequences perfectly matching the consensus motif for
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the PRDM9 A-variant within PRS2 are important for PRDM9 bind-
ing and are associated with the higher NAHR activity in PRS2
when compared with PRS1 that lacks a binding site perfectly
matching the consensus motif in its core.
According to the DNA DSB repair model of meiotic recombin-
ation, subsequent to the DSB, single-stranded DNA ends invade
the homologous sequences (Fig. 4). The DSB is then repaired by
the reciprocal exchange of DNA, forming a dHj associated with
branch migration. Consequently, the location of the crossover is
different from the site of the original DSB (Fig. 4) (72). PRDM9 di-
rects the recombination-initiating SPO11-mediated DSB close to
its binding site (21,28,73). In the mouse, PRDM9 catalyses the tri-
methylation of histone H3 at lysine 4 and reorganizes nucleo-
somes within recombination hotspots in a symmetrical pattern
around a central nucleosome-depleted region (NDR) of ∼120 bp.
Within the NDR, the DSB occurs close to the PRDM9 binding
site (Fig. 5) (48,74). Further, branchmigration of the dHj is limited
to the region of nucleosomes trimethylated by PRDM9 encom-
passing 1000–2500 bp (48). Accordingly, the extent of the dHj is
determined by the number of nucleosomes with PRDM9-modi-
ﬁed H3K4me3 and should encompass 1 up to 2.5 kb.
If we apply this model of PRDM9 activity to NAHR within PRS2
causing type 1 NF1 deletions, the SERs determined in the current
work represent the regions of dHj resolution or crossover, whilst
the DSB occurred close to the predicted PRDM9 binding sites. In
view of the fact that a dHj is a symmetrical structure, the distance
between the SER and the PRDM9 binding site corresponds to half
the length of the dHj (Fig. 4). We observed distances between the
SERs and the predicted PRDM9 A-variant binding sites within
PRS2 of up to 1367 bp (Supplementary Material, Table S24). Since
these regions represent only half the length of the dHj as shown
inFigure 4, it followsthat theentireH3K4me3 track lengthmediated
by PRDM9, and hence the extent of the dHjs underlying the NAHR
events causing PRS2-mediateddeletions, should encompass 2–3 kb.
This estimate of the H3K4me3 track length mediated by PRDM9 is
thus similar to that observed at mouse AHR hotspots (48).
We conclude that the high frequency of NAHR-associated
crossovers within PRS2 is potentiated by optimal conditions for
PRDM9 binding and effective reorganization of nucleosomes
leading to stable dHj formation and branch migration. The
sequence features responsible for providing these optimal con-
ditions for PRDM9 action within PRS2 are likely to include
open chromatin conformation as well as a speciﬁc histone
modiﬁcation pattern preceding PRDM9-mediated nucleosome
reorganization. By contrast, within PRS1, the conditions for
PRDM9 binding and nucleosome reorganization are probably
suboptimal owing to the lack of PRDM9 binding sites perfectly
matching the consensus motif leading to a reduced number of
crossoverswithin PRS1when comparedwith PRS2. These conclu-
sions are supported by recent studies showing that PRDM9 not
only activates AHR hotspots but is also responsible for quantita-
tive modulation of the recombination rate in mice (75).
In summary, our ﬁndings indicate that a number of different
chromosomal features are likely to play a role in inﬂuencing the
positional preference of NAHR within the NF1-REPs and the
NAHR hotspots. These features include the presence of several
100 bp segments of uninterrupted sequence identity, the number
of PRDM9 binding sites perfectly matching the consensus motif
of themost frequent PRDM9 variants, speciﬁc patterns of histone
modiﬁcation and an open chromatin conformation that facili-
tates PRDM9 binding. We postulate that the activity of other
NAHR hotspots elsewhere in the human genome may be inﬂu-
enced by similar mechanisms.
Materials and Methods
Patients
The 68NF1 patients investigated here to determine the frequency
of bonaﬁde type 1NF1 deletionswere referred by the NF1 clinic at
the Department of Neurology, University Hospital Hamburg Ep-
pendorf, Germany (UKE cohort). They were initially analysed by
microsatellite markers located within the NF1 gene region and
subsequently by MLPA (P122 NF1 area probemix, version C2,
MRC Holland, The Netherlands) using blood-derived genomic
DNA. When a type 1 NF1 deletion was tentatively identiﬁed by
MLPA, the patient DNA was further investigated by breakpoint-
spanning PCRs in order to conﬁrm that the breakpoints were in-
deed locatedwithin the PRS1 and PRS2NAHRhotspots. Twentyof
these 68 type 1NF1 deletions had already been previously studied
(7), but the remaining 48 deletions had not previously been ana-
lysed systematically.
In addition to these 68 patients, we analysed 41 patients with
putative type 1NF1deletions as suggestedby initialMLPA screen-
ing performed at the Medical Genomics Laboratory, Department
of Genetics, University of Alabama at Birmingham, USA (UAB co-
hort). In the present study, breakpoint-spanning PCRs were per-
formed using blood-derived genomic DNA from the patients
from the UAB cohort in order to identify deletions with break-
points located within the NAHR hotspots PRS1 and PRS2.
Figure 5.Model of PRDM9 activation of recombination hotspots according to Baker et al. (48). PRDM9 binds to theDNAwithin the hotspot core via its zinc ﬁnger domain and
modiﬁes surrounding nucleosomes by trimethylation at histone H3. PRDM9-modiﬁed nucleosomes are remodelled to create a central NDR. Subsequently, a DNA DSB is
introduced within the NDR, spanning ∼120 bp, by meiosis-speciﬁc SPO11. The location of the meiotic crossover (e.g. the branch migration) is constrained by PRDM9-
dependent chromatin modiﬁcation and hence is restricted to the nucleosomes modiﬁed by PRDM9.
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All patients fulﬁlled the diagnostic criteria for NF1 and gave
their informed consent for the genetic analysis to be performed.
This study was approved by the Institutional Review Boards of
the participating institutions.
Breakpoint-spanning PCRs, determination of SERs
and gene conversion
Weperformed breakpoint-spanning PCRswith primers previous-
ly described or newly established for the purposes of this study
(Supplementary Material, Table S1). The PCRs were performed
using the Expand Long Range dNTPack (Roche) and 400 ng gen-
omic DNA derived from blood of the patients. The breakpoint-
spanning PCRs performed to detect SERs within PRS2 have been
established previously (7), but those performed to identify break-
points locatedwithin PRS1were newly designed. The breakpoint-
spanning PCR products (BSPs) were sequenced to determine the
SERs that were identiﬁed by means of PSVs (Supplementary Ma-
terial, Table S2). PSVs are non-polymorphic sequence differences
between NF1-REPa and NF1-REPc. In order to identify the SERs,
we also used SNPs with anMAF of ≤1% (Supplementary Material,
Tables S3 and S4).
PSVswere distinguished fromSNPs by cross-comparisonwith
all variants located within these regions as identiﬁed by the 1000
Genomes Project (http://www.1000genomes.org/home) (ftp://ftp.
1000genomes.ebi.ac.uk/vol1/ftp/release/20110521/ALL.chr17.
phase1_release_v3.20101123.snps_indels_svs.genotypes.vcf.gz)
(34). Discrimination of PSVs from SNPswith anMAF of ≥1% is im-
portant in order to determine the SERs, and ascertain the gene
conversion patterns, since polymorphisms with high MAFs are
unsuitable for determining the origin of the respective nucleo-
tides within BSPs.
Putative gene conversion events detected in the BSPs were
further investigated by analysing the nucleotide patterns of the
wild-type PRS1 or PRS2 sequences in the parents of the patients.
Type 1 NF1 deletions arise in the germlines of otherwise healthy
parents by meiotic NAHR affecting single germ cells. The paren-
tal origin of the deletions was determined by microsatellite
marker analysis. Non-recombinant wild-type sequences from
NF1-REPa and NF1-REPc encompassing the PRS2 or PRS1 regions
were PCR-ampliﬁed from genomic blood-derived DNA of the
healthy parents using the Expand Long Range dNTPack (Roche)
and primers listed in Supplementary Material, Tables S13 and
S14. Sequence analysis of the PCR fragments encompassing the
wild-type PRS2 or PRS1 regions ampliﬁed from the transmitting
parents enabled us to ascertainwhether the gene conversion pat-
terns detected in the breakpoint-ﬂanking sequences of their chil-
dren represented variant haplotypes present already in the
parents prior to the NAHR events or whether these gene conver-
sion patterns were associated with the deletion-causing NAHR.
The phase of the haplotypes of the wild-type PRS1 and PRS2 re-
gions in the parents was determined by cloning of the PCR pro-
ducts and sequence analysis of single clones.
PRDM9 binding site prediction
Binding sites for the PRDM9 protein A- and C-variants were pre-
dicted within PRS1, PRS2 and 10 kb regions ﬂanking these hot-
spots on either side. The extent and genomic positions of the
analysed regions are indicated in Supplementary Material,
Table S27 and Figure 1. To predict putative PRDM9 binding
sites, we screened the reference sequence of the human genome
(hg19) using the JavaScript software DNA Pattern Find, Sequence
Manipulation Suites (Version 2) (http://www.bioinformatics.org/
sms2/dna_pattern.html) (76). Predicted binding sites for the
PRDM9 A-variant exhibited a perfect match to the consensus
motif 5′ CCNCCNTNNCCNC 3′ (31), whereas predicted binding
sites for the PRDM9 C-variant showed 100% sequence identity
to the consensus motif 5′ CCNCNNTNNNCNTNNC 3′ (32,33).
The PRS1 region was also screened for the presence of PRDM9
A-variant binding sites exhibiting only seven of eight matches
to the consensus binding motif 5′ CCNCCNTNNCCNC 3′.
Genotyping of PRDM9 alleles
To determine the genotype of PRDM9 in the parents of patients
with type 1 NF1 deletions, we performed PCR using genomic
blood-derived DNA and primers HsPrdm9-F3 (5′ TGTAAGGAAT
GACACTGCCCTGA 3′) and HsPrdm9-R1 (5′ ATGTCCCCCGAA
CACTTACAGAA 3′) (18). The PCR was performed with the Expand
Long Range dNTPack (Roche). The primers used to fully sequence
the PCR fragments of the PRDM9 alleles were PN1.2F (5′ TGAATC
CAGGGAACACAGGC 3′) and PN2.4R (5′ GCAAGTGTGTGGTGAC
CACA 3′) (19).
Analysis of sequence homology
Sequence homology between NF1-REPa and NF1-REPc was deter-
mined by BLAST sequence alignments (https://blast.ncbi.nlm.nih.
gov/Blast.cgi?PAGE_TYPE=BlastSearch&BLAST_SPEC=blast2seq&
LINK_LOC=align2seq). The chromosomal positions of the regions
analysed are listed in Supplementary Material, Table S27 and
Figure 1. The location and extent of the regions exhibiting se-
quence identity were graphically displayed using the mVISTA
tool (http://genome.lbl.gov/vista/mvista/submit.shtml).
Recombination rates
The recombination rates in PRS1, PRS2 and their ﬂanking regions
were extracted from the Phase II HapMap data set compiling
information from over 3.1 million SNPs genotyped in 270 indivi-
duals of African, Asian and European origin (77). Fine-scale re-
combination rates were determined from genetic variation
patterns (78) and were downloaded from the HapMap website
(http://hapmap.ncbi.nlm.nih.gov/downloads/recombination/),
and converted to GRCh37 (hg19).
GC content
The GC content of the genomic regions encompassing nucleotide
positions 28 962 945–29 003 359 (according to hg19), including the
PRS1 and PRS2 hotspots as well as 10 kb centromeric to PRS1 and
4 kb telomeric to PRS2, was analysed using the Visual Gene De-
veloper 1.7 (http://visualgenedeveloper.net/index.html).
Supplementary Material
Supplementary material is available at HMG online.
Conﬂict of Interest statement. None declared.
Funding
This work was supported by the Deutsche Forschungsge-
meinschaft (KE 724/12-1 given to H.K.-S.).
References
1. Friedman, J.M. and Riccardi, V.M. (1999) Clinical and epide-
miologic features. In Friedman, J.M., Gutmann, D.H., MacCol-
lin, M. and Riccardi, V.M. (eds), Neuroﬁbromatosis: Phenotype,
Human Molecular Genetics, 2016, Vol. 25, No. 3 | 493
 at Cardiff U
niversity on M
arch 4, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
Natural History and Pathogenesis, 3rd edn. Johns Hopkins Uni-
versity Press, Baltimore, USA, pp. 29–86.
2. Lammert, M., Friedman, J.M., Kluwe, L. and Mautner, V.F.
(2005) Prevalence of neuroﬁbromatosis 1 in German children
at elementary school enrolment. Arch. Dermatol., 141, 71–74.
3. Kluwe, L., Siebert, R., Gesk, S., Friedrich, R.E., Tinschert, S.,
Kehrer-Sawatzki, H. and Mautner, V.F. (2004) Screening 500
unselected neuroﬁbromatosis 1 patients for deletions of the
NF1 gene. Hum. Mutat., 23, 111–116.
4. Kehrer-Sawatzki, H. and Cooper, D.N. (2012) NF1 microdele-
tions and their underlying mutational mechanisms,
Chap. 14. In Upadhyaya, M. and Cooper, D.N. (eds), Neuro-
ﬁbromatosis Type 1: Molecular and Cellular Biology, Springer,
Heidelberg, Germany, Vol. 1, pp. 187–211.
5. Wimmer, K., Yao, S., Claes, K., Kehrer-Sawatzki, H., Tinschert,
S., De Raedt, T., Legius, E., Callens, T., Beiglböck, H., Maertens,
O. et al. (2006) Spectrum of single- and multiexon NF1 copy
number changes in a cohort of 1, 100 unselectedNF1 patients.
Genes Chromosomes Cancer, 45, 265–276.
6. De Raedt, T., Stephens, M., Heyns, I., Brems, H., Thijs, D., Mes-
siaen, L., Stephens, K., Lazaro, C., Wimmer, K., Kehrer-Sa-
watzki, H. et al. (2006) Conservation of hotspots for
recombination in low-copy repeats associated with the NF1
microdeletion. Nat. Genet., 38, 1419–1423.
7. Bengesser, K., Vogt, J., Mussotter, T., Mautner, V.F., Messiaen,
L., Cooper, D.N. and Kehrer-Sawatzki, H. (2014) Analysis of
crossover breakpoints yields new insights into the nature of
the gene conversion events associated with large NF1 dele-
tions mediated by nonallelic homologous recombination.
Hum. Mutat., 35, 215–226.
8. Liu, P., Carvalho, C.M., Hastings, P.J. and Lupski, J.R. (2012) Me-
chanisms for recurrent and complex human genomic rear-
rangements. Curr. Opin. Genet. Dev., 22, 211–220.
9. Lupski, J.R. (2004) Hotspots of homologous recombination in
the human genome: not all homologous sequences are
equal. Genome Biol., 5, 242.
10. Liu, P., Lacaria, M., Zhang, F., Withers, M., Hastings, P.J. and
Lupski, J.R. (2011) Frequency of nonallelic homologous re-
combination is correlated with length of homology: evidence
that ectopic synapsis precedes ectopic crossing-over.
Am. J. Hum. Genet., 89, 580–588.
11. Baudat, F., Imai, Y. and de Massy, B. (2013) Meiotic recombin-
ation in mammals: Localization and regulation. Nat. Rev.
Genet., 14, 794–806.
12. Coutton, C., Abada, F., Karaouzene, T., Sanlaville, D., Satre, V.,
Lunardi, J., Jouk, P.S., Arnoult, C., Thierry-Mieg, N. and Ray,
P.F. (2013) Fine characterisation of a recombination hotspot
at theDPY19L2 locus and resolution of the paradoxical excess
of duplications over deletions in the general population. PLoS
Genet., 9, e1003363.
13. Elinati, E., Kuentz, P., Redin, C., Jaber, S., Vanden Meerschaut,
F., Makarian, J., Koscinski, I., Nasr-Esfahani,M.H., Demirol, A.,
Gurgan, T. et al. (2012) Globozoospermia is mainly due to
DPY19L2 deletion via non-allelic homologous recombination
involving two recombination hotspots. Hum. Mol. Genet., 21,
3695–3702.
14. Lindsay, S.J., Khajavi, M., Lupski, J.R. and Hurles, M.E. (2006)
A chromosomal rearrangement hotspot can be identiﬁed
from population genetic variation and is coincident with
a hotspot for allelic recombination. Am. J. Hum. Genet., 79,
890–902.
15. MacArthur, J.A., Spector, T.D., Lindsay, S.J., Mangino, M., Gill,
R., Small, K.S. and Hurles, M.E. (2014) The rate of nonallelic
homologous recombination in males is highly variable,
correlated between monozygotic twins and independent of
age. PLoS Genet., 10, e1004195.
16. Paigen, K. and Petkov, P. (2010) Mammalian recombination
hot spots: Properties, control and evolution. Nat. Rev. Genet.,
11, 221–233.
17. Turner, D.J., Miretti, M., Rajan, D., Fiegler, H., Carter, N.P.,
Blayney, M.L., Beck, S. and Hurles, M.E. (2008) Germline
rates of de novo meiotic deletions and duplications causing
several genomic disorders. Nat. Genet., 40, 90–95.
18. Baudat, F., Buard, J., Grey, C., Fledel-Alon, A., Ober, C., Prze-
worski, M., Coop, G. and de Massy, B. (2010) PRDM9 is a
major determinant of meiotic recombination hotspots in hu-
mans and mice. Science, 327, 836–840.
19. Berg, I.L., Neumann, R., Lam, K.W., Sarbajna, S., Odenthal-
Hesse, L., May, C.A. and Jeffreys, A.J. (2010) PRDM9 variation
strongly inﬂuences recombination hot-spot activity andmei-
otic instability in humans. Nat. Genet., 42, 859–863.
20. Billings, T., Parvanov, E.D., Baker, C.L., Walker, M., Paigen, K.
and Petkov, P.M. (2013) DNA binding speciﬁcities of the long
zinc-ﬁnger recombination protein PRDM9. Genome Biol., 14,
R35.
21. Grey, C., Barthès, P., Chauveau-Le Friec, G., Langa, F., Baudat,
F. and de Massy, B. (2011) Mouse PRDM9 DNA-binding
speciﬁcity determines sites of histone H3 lysine 4 trimethy-
lation for initiation of meiotic recombination. PLoS Biol., 9,
e1001176.
22. Myers, S., Bowden, R., Tumian, A., Bontrop, R.E., Freeman, C.,
MacFie, T.S., McVean, G. and Donnelly, P. (2010) Drive against
hotspot motifs in primates implicates the PRDM9 gene in
meiotic recombination. Science, 327, 876–879.
23. Parvanov, E.D., Petkov, P.M. and Paigen, K. (2010) Prdm9 con-
trols activation of mammalian recombination hotspots. Sci-
ence, 327, 835.
24. Berg, I.L., Neumann, R., Sarbajna, S., Odenthal-Hesse, L., But-
ler, N.J. and Jeffreys, A.J. (2011) Variants of the protein PRDM9
differentially regulate a set of humanmeiotic recombination
hotspots highly active in African populations. Proc. Natl. Acad.
Sci. USA, 108, 12378–12383.
25. Buard, J., Rivals, E., Dunoyer de Segonzac, D., Garres, C., Cami-
nade, P., deMassy, B. and Boursot, P. (2014) Diversity of Prdm9
zinc ﬁnger array in wild mice unravels new facets of the evo-
lutionary turnover of this coding minisatellite. PLoS One, 9,
e85021.
26. Jeffreys, A.J., Cotton, V.E., Neumann, R. and Lam, K.W. (2013)
Recombination regulator PRDM9 inﬂuences the instability of
its own coding sequence in humans. Proc. Natl. Acad. Sci. USA,
110, 600–605.
27. Oliver, P.L., Goodstadt, L., Bayes, J.J., Birtle, Z., Roach, K.C.,
Phadnis, N., Beatson, S.A., Lunter, G., Malik, H.S. and Ponting,
C.P. (2009) Accelerated evolution of the Prdm9 speciation gene
across diverse metazoan taxa. PLoS Genet., 5, e1000753.
28. Brick, K., Smagulova, F., Khil, P., Camerini-Otero, R.D. and Pet-
ukhova, G.V. (2012) Genetic recombination is directed away
from functional genomic elements in mice. Nature, 485,
642–645.
29. Pratto, F., Brick, K., Khil, P., Smagulova, F., Petukhova, G.V. and
Camerini-Otero, R.D. (2014) DNA recombination. Recombin-
ation initiation maps of individual human genomes. Science,
346, 1256442.
30. Dittwald, P., Gambin, T., Szafranski, P., Li, J., Amato, S., Divon,
M.Y., Rodríguez Rojas, L.X., Elton, L.E., Scott, D.A., Schaaf, C.P.
et al. (2013) NAHR-mediated copy-number variants in a clin-
ical population: mechanistic insights into both genomic dis-
orders and Mendelizing traits. Genome Res., 23, 1395–1409.
494 | Human Molecular Genetics, 2016, Vol. 25, No. 3
 at Cardiff U
niversity on M
arch 4, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
31. Myers, S., Freeman, C., Auton, A., Donnelly, P. andMcVean, G.
(2008) A common sequence motif associated with recombin-
ation hot spots and genome instability in humans. Nat.
Genet., 40, 1124–1129.
32. Hinch, A.G., Tandon, A., Patterson, N., Song, Y., Rohland, N.,
Palmer, C.D., Chen, G.K., Wang, K., Buxbaum, S.G., Akylbeko-
va, E.L. et al. (2011) The landscape of recombination in African
Americans. Nature, 476, 170–175.
33. Kong, A., Thorleifsson, G., Gudbjartsson, D.F., Masson, G., Si-
gurdsson, A., Jonasdottir, A., Walters, G.B., Jonasdottir, A.,
Gylfason, A., Kristinsson, K. et al. (2010) Fine-scale recombin-
ation rate differences between sexes, populations and indivi-
duals. Nature, 467, 1099–1103.
34. 1000 Genomes Project ConsortiumAbecasis, G.R., Auton, A.,
Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E.,
Kang, H.M.,Marth, G.T. andMcVean, G.A. (2012) An integrated
map of genetic variation from 1, 092 human genomes.Nature,
491, 56–65.
35. Alemany-Schmidt, A., Navarro-Palou, M., Voltes-Cobo, A.,
Rosell, J., Heine-Suñer, D., Picornell, A. and Oliver-Bonet, M.
(2014) Geographical genetic variability: a factor to consider
when assessing clinical implications of PRDM9. Mol. Genet.
Genomic Med., 2, 201–203.
36. Borel, C., Cheung, F., Stewart, H., Koolen, D.A., Phillips, C.,
Thomas, N.S., Jacobs, P.A., Eliez, S. and Sharp, A.J. (2012)
Evaluation of PRDM9 variation as a risk factor for recurrent
genomic disorders and chromosomal non-disjunction.
Hum. Genet., 131, 1519–1524.
37. Hussin, J., Sinnett, D., Casals, F., Idaghdour, Y., Bruat, V., Sail-
lour, V., Healy, J., Grenier, J.C., de Malliard, T., Busche, S. et al.
(2013) Rare allelic forms of PRDM9 associated with childhood
leukemogenesis. Genome Res., 23, 419–430.
38. Woodward, E.L., Olsson, M.L., Johansson, B. and Paulsson, K.
(2014) Allelic variants of PRDM9 associated with high
hyperdiploid childhood acute lymphoblastic leukaemia.
Br. J. Haematol., 166, 947–949.
39. ENCODE Project ConsortiumDunham, I., Kundaje, A., Aldred,
S.F., Collins, P.J., Davis, C.A., Doyle, F., Epstein, C.B., Frietze, S.,
Harrow, J. et al. (2012) An integrated encyclopedia of DNA ele-
ments in the human genome. Nature, 489, 57–74.
40. López Correa, C., Brems, H., Lázaro, C., Marynen, P. and Le-
gius, E. (2000) Unequal meiotic crossover: a frequent cause
of NF1 microdeletions. Am. J. Hum. Genet., 66, 1969–1674.
41. Dihazi, H., Dihazi, G.H., Nolte, J., Meyer, S., Jahn, O., Müller, G.
A. and Engel, W. (2009) Multipotent adult germline stem cells
and embryonic stem cells: comparative proteomic approach.
J. Proteome Res., 8, 5497–5510.
42. De Raedt, T., Brems, H., Lopez-Correa, C., Vermeesch, J.R.,
Marynen, P. and Legius, E. (2004) Genomic organization and
evolution of the NF1 microdeletion region. Genomics, 84,
346–360.
43. Waldman, A.S. (2008) Ensuring the ﬁdelity of recombination
in mammalian chromosomes. Bioessays, 30, 1163–1171.
44. Dorschner, M.O., Sybert, V.P., Weaver, M., Pletcher, B.A. and
Stephens, K. (2000) NF1 microdeletion breakpoints are clus-
tered at ﬂanking repetitive sequences. Hum. Mol. Genet., 9,
35–46.
45. Jenne, D.E., Tinschert, S., Reimann, H., Lasinger, W., Thiel, G.,
Hameister, H. and Kehrer-Sawatzki, H. (2001) Molecular char-
acterization and gene content of breakpoint boundaries in
patients with neuroﬁbromatosis type 1 with 17q11.2 micro-
deletions. Am. J. Hum. Genet., 69, 516–527.
46. Forbes, S.H., Dorschner, M.O., Le, R. and Stephens, K. (2004)
Genomic context of paralogous recombination hotspots
mediating recurrent NF1 regionmicrodeletion. Genes Chromo-
somes Cancer, 41, 12–15.
47. López-Correa, C., Dorschner, M., Brems, H., Lázaro, C., Clem-
enti, M., Upadhyaya,M., Dooijes, D., Moog, U., Kehrer-Sawatz-
ki, H., Rutkowski, J.L. et al. (2001) Recombination hotspot in
NF1 microdeletion patients. Hum. Mol. Genet., 10, 1387–1392.
48. Baker, C.L., Walker, M., Kajita, S., Petkov, P.M. and Paigen, K.
(2014) PRDM9 binding organizes hotspot nucleosomes and
limits Holliday junction migration. Genome Res., 24, 724–732.
49. Arbeithuber, B., Betancourt, A.J., Ebner, T. and Tiemann-
Boege, I. (2015) Crossovers are associated with mutation
and biased gene conversion at recombination hotspots.
Proc. Natl. Acad. Sci. USA, 112, 2109–2114.
50. Capra, J.A. and Pollard, K.S. (2011) Substitution patterns are
GC-biased in divergent sequences across the metazoans.
Genome Biol. Evol., 3, 516–527.
51. Duret, L. and Arndt, P.F. (2008) The impact of recombination
on nucleotide substitutions in the human genome. PLoS
Genet., 4, e1000071.
52. Lesecque, Y., Mouchiroud, D. and Duret, L. (2013) GC-biased
gene conversion in yeast is speciﬁcally associatedwith cross-
overs: molecular mechanisms and evolutionary signiﬁcance.
Mol. Biol. Evol., 30, 1409–1419.
53. Odenthal-Hesse, L., Berg, I.L., Veselis, A., Jeffreys, A.J. and
May, C.A. (2014) Transmission distortion affecting human
noncrossover but not crossover recombination: a hidden
source of meiotic drive. PLoS Genet., 10, e1004106.
54. Williams, A.L., Genovese, G., Dyer, T., Altemose, N., Truax, K.,
Jun, G., Patterson, N., Myers, S.R., Curran, J.E., Duggirala, R.
et al. (2015) Non-crossover gene conversions show strong GC
bias and unexpected clustering in humans. Elife, 25, 4.
55. Bi, W., Park, S.S., Shaw, C.J., Withers, M.A., Patel, P.I. and
Lupski, J.R. (2003) Reciprocal crossovers and a positional
preference for strand exchange in recombination events re-
sulting in deletion or duplication of chromosome 17p11.2.
Am. J. Hum. Genet., 73, 1302–1315.
56. Peng, Z., Zhou, W., Fu, W., Du, R., Jin, L. and Zhang, F. (2015)
Correlation between frequency of non-allelic homologous re-
combination and homology properties: evidence from hom-
ology-mediated CNV mutations in the human genome.
Hum. Mol. Genet., 24, 1225–1233.
57. Borde, V., Robine, N., Lin, W., Bonﬁls, S., Géli, V. and Nicolas,
A. (2009) HistoneH3 lysine 4 trimethylationmarksmeiotic re-
combination initiation sites. EMBO J., 28, 99–111.
58. Buard, J., Barthès, P., Grey, C. and de Massy, B. (2009) Distinct
histone modiﬁcations deﬁne initiation and repair of meiotic
recombination in the mouse. EMBO J., 28, 2616–2624.
59. Smagulova, F., Gregoretti, I.V., Brick, K., Khil, P., Camerini-
Otero, R.D. and Petukhova, G.V. (2011) Genome-wide analysis
reveals novel molecular features of mouse recombination
hotspots. Nature, 472, 375–378.
60. Szekvolgyi, L., Ohta, K. andNicolas, A. (2015) Initiation ofmei-
otic homologous recombination: ﬂexibility, impact of histone
modiﬁcations, and chromatin remodeling. Cold Spring Harb
Perspect. Biol., 7, a016527.
61. Yamada, S., Ohta, K. and Yamada, T. (2013) Acetylated his-
tone H3K9 is associated with meiotic recombination hot-
spots, and plays a role in recombination redundantly with
other factors including the H3K4 methylase Set1 in ﬁssion
yeast. Nucleic Acids Res., 41, 3504–3517.
62. Zeng, J. and Yi, S.V. (2014) Speciﬁc modiﬁcations of histone
tails, but not DNAmethylation,mirror the temporal variation
of mammalian recombination hotspots. Genome Biol. Evol., 6,
2918–2929.
Human Molecular Genetics, 2016, Vol. 25, No. 3 | 495
 at Cardiff U
niversity on M
arch 4, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
63. Zhang, L., Ma, H. and Pugh, B.F. (2011) Stable and dynamic nu-
cleosome states during a meiotic developmental process.
Genome Res., 21, 875–884.
64. Szafranski, P., Schaaf, C.P., Person, R.E., Gibson, I.B., Xia, Z.,
Mahadevan, S., Wiszniewska, J., Bacino, C.A., Lalani, S.,
Potocki, L. et al. (2010) Structures andmolecular mechanisms
for common 15q13.3 microduplications involving CHRNA7:
benign or pathological? Hum. Mutat., 31, 840–850.
65. Visser, R., Shimokawa, O., Harada, N., Kinoshita, A., Ohta, T.,
Niikawa, N. and Matsumoto, N. (2005) Identiﬁcation of a
3.0-kb major recombination hotspot in patients with Sotos
syndrome who carry a common 1.9-Mb microdeletion.
Am. J. Hum. Genet., 76, 52–67.
66. Abyzov, A., Li, S., Kim, D.R., Mohiyuddin, M., Stutz, A.M.,
Parrish, N.F., Mu, X.J., Clark, W., Chen, K., Hurles, M. et al.
(2015) Analysis of deletion breakpoints from1, 092 humans re-
veals details of mutation mechanisms. Nat. Commun., 6, 7256.
67. Jeffreys, A.J., Kauppi, L. and Neumann, R. (2001) Intensely
punctate meiotic recombination in the class II region of the
major histocompatibility complex. Nat. Genet., 29, 217–222.
68. Jeffreys, A.J. and Neumann, R. (2002) Reciprocal crossover
asymmetry and meiotic drive in a human recombination
hot spot. Nat. Genet., 31, 267–271.
69. Jeffreys, A.J. and Neumann, R. (2005) Factors inﬂuencing re-
combination frequency and distribution in a human meiotic
crossover hotspot. Hum. Mol. Genet., 14, 2277–2287.
70. Ségurel, L., Lefﬂer, E.M. and Przeworski, M. (2011) The case of
the ﬁckle ﬁngers: how the PRDM9 zinc ﬁnger protein speciﬁes
meiotic recombination hotspots in humans. PLoS Biol., 9,
e1001211.
71. Walker, M., Billings, T., Baker, C.L., Powers, N., Tian, H., Saxl,
R.L., Choi, K., Hibbs, M.A., Carter, G.W., Handel, M.A. et al.
(2015) Afﬁnity-seq detects genome-wide PRDM9 binding
sites and reveals the impact of prior chromatinmodiﬁcations
on mammalian recombination hotspot usage. Epigenetics
Chromatin, 8, 31.
72. Neale, M.J. and Keeney, S. (2006) Clarifying the mechanics of
DNA strand exchange in meiotic recombination. Nature, 442,
153–158.
73. Keeney, S. (2008) Spo11 and the formation of DNA double-
strand breaks in meiosis. Genome Dyn. Stab., 2, 81–123.
74. de Massy, B. (2013) Initiation of meiotic recombination: how
and where? Conservation and speciﬁcities among eukar-
yotes. Annu. Rev. Genet., 47, 563–599.
75. Baker, C.L., Petkova, P., Walker, M., Flachs, P., Mihola, O.,
Trachtulec, Z., Petkov, P.M. and Paigen, K. (2015)Multimer for-
mation explains allelic suppression of PRDM9 recombination
hotspots. PLoS Genet., 11, e1005512.
76. Stothard, P. (2000) The sequence manipulation suite: Java-
Script programs for analyzing and formatting protein and
DNA sequences. Biotechniques, 28, 1102–1104.
77. International HapMap ConsortiumFrazer, K.A., Ballinger, D.
G., Cox, D.R., Hinds, D.A., Stuve, L.L., Gibbs, R.A., Belmont, J.
W., Boudreau, A., Hardenbol, P. et al. (2007) A second gener-
ation human haplotype map of over 3.1 million SNPs. Nature,
449, 851–861.
78. McVean, G.A., Myers, S.R., Hunt, S., Deloukas, P., Bentley, D.R.
and Donnelly, P. (2004) The ﬁne-scale structure of recom-
bination rate variation in the human genome. Science, 304,
581–584.
496 | Human Molecular Genetics, 2016, Vol. 25, No. 3
 at Cardiff U
niversity on M
arch 4, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
